European Medicines Agency update on combined contraceptives and risk of venous thromboembolism

Source: Eur Meds Agency Area: News The European Medicines Agency has issuing this update in response to growing media reports about combined contraceptives and venous thromboembolism (VTE). The Agency states it is well-established that these agents carry a very rare risk of VTW, and this risk differs between types of combined contraceptives. It stresses that these products are constantly and rigorously kept under close monitoring and there is currently no new evidence that would suggest any change to the known safety profile of any combined contraceptives marketed at present. Therefore, there is no reason for any woman to stop using her contraception.
Source: NeLM - Cardiovascular Medicine - Category: Cardiology Source Type: news